Active Surveillance Use for Favorable-Risk Prostate Cancer in a Veterans Affairs Population. Lee G, Bihn JR, Culnan JM, La J, et al. JAMA 2026 Aug 13. doi: 10.1001/jama.2026.13471.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee G, Bihn JR, Culnan JM, La J, et al. Active Surveillance Use for Favorable-Risk Prostate Cancer in a Veterans Affairs Population. JAMA 2026 Aug 13. doi: 10.1001/jama.2026.13471.
PMID: 42593769